GABRB3 and Lennox-Gastaut syndrome: A woman with Lennox-Gastaut syndrome (LGS) from a disease-causing variant in GABRB3 experienced a sustained, dose-dependent decrease in epileptiform activity on EEG after starting vinpocetine, a synthetic derivative of vincamine which is an alkaloid derived from the periwinkle plant.